Blog
The Changing Shape of Optofluidics R&D
BlogLife science businesses are facing growing demand to keep pace in an era of fast-evolving technology. By recognising the potential challenges, a growing number of companies are leveraging the resources and creativity of their suppliers. We took a look at the landscape of optofluidics R&D.
Read More
Entering the Golden Era of Lateral Flow Diagnostics
BlogGold nanorods are increasingly being used in diagnostic applications, such as lateral flow assays. To learn more, we got in touch with Darren Rowles, CEO of Sona Nanotech Inc. who provides insights on diagnostic industry trends, and tells us about the source, application and production process of gold nanoparticles.
Read More
The Liquid Biopsy Trends Transforming Cancer Detection and Treatment
BlogLiquid biopsy is a less invasive approach compared to traditional surgical biopsies. By collecting a simple blood sample and analyzing circulating tumor DNA (ctDNA), cancer researchers and healthcare professionals can access a myriad of information about a patient’s tumor.
Read More
Sustainability Through Innovation
BlogWith growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.
Read More
Students Get Hands-on with Mass Spectrometry
BlogWe spoke to Dr Jonathan Jones from Waters Corporation, to learn more about the new initiative that they and Swansea University are leading to give students hands-on experience of mass spectrometry.
Read More
The Search Begins: Urinary Biomarkers that Indicate Pulmonary Exacerbation in Cystic Fibrosis
BlogA clinical trial has been launched to identify urine-based biomarkers which indicate lung flare-ups in cystic fibrosis. Researchers believe point-of-care monitoring will help people get treatment faster, improve patient outcomes and reduce healthcare costs.
Read More
Why is China Becoming a Microfluidics Manufacturing Superpower?
BlogMany Chinese microfluidics companies are emerging and expanding, and it could be game-changing for the industry. We spoke with Yole Développement analyst, Sébastien Clerc, to learn more.
Read More
Say Hello to Regenerative Medicine and Goodbye to Back Pain
BlogDegenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.
Read More
A Move Towards Precise Management of Bacterial Infections
BlogFollowing the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.
Read More
Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer
BlogDuring this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.
Read More
